EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease

Eiko N Minakawa iD, Kensuke Owari, Naotake Nogami, Terumi Nakatani, Masashi Koizumi, Akiyo Kawanobe, Yosuke Saga iD, Moeko Kudo, Satoru Noguchi iD, Takashi Hanakawa iD, Yuki Hori, Hidemi Numazawa und 7 weitere

Disease Models & Mechanisms · 2025

DOI: 10.1242/dmm.052470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2025. Verfasst von Eiko N Minakawa und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurophysiology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan. Hauptthemen laut MEDLINE: Callithrix, Peptides, Germ Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center of Neurology and Psychiatry, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases, including polyglutamine diseases, remain a clinical challenge, partly because of limited animal models that recapitulate human disease. Here, we describe a second-generation transgenic marmoset model of spinocerebellar ataxia 3 (SCA3), a polyglutamine disease, which stably expresses expanded CAG repeats in ataxin 3 (ATXN3). All five offspring of the founder marmoset harbored the transgene with reduced transgene integration sites compared with the founder and without repeat instability or genetic mosaicism, offering improved construct validity. Three of the five marmosets developed progressive motor impairments that segregated into two distinct phenotypes – early onset with rapid progression and late onset with mild progression – accompanied by corresponding patterns in body weight gain and grip strength. Pathological analysis revealed cerebellar Purkinje cell loss, spinal cord neurodegeneration and widespread intranuclear inclusions. The severity of motor phenotypes correlated with transgene expression levels in disease-relevant brain regions, including the cerebellum and spinal cord. By overcoming the translational limitations of rodent systems, our second-generation model offers a powerful platform for investigating disease mechanisms and testing potential therapeutics, advancing the utility of transgenic marmosets as clinically relevant models of neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CallithrixPeptidesGerm CellsAnimalsDisease Models, AnimalAnimals, Genetically ModifiedSpinal CordPhenotypeAtaxin-3Machado-Joseph DiseasePurkinje CellsMaleTransgenesFemaleHumansCerebellumBrain

Stichwörter der Autor:innen

Common marmosetGermline transmissionHome-cage behavior assessmentMachado–Joseph diseasePolyglutamine diseasesSpinocerebellar ataxia 3

Substanzen

polyglutaminePeptidesAtaxin-3

Autor:innen und Institutionen

  • Department of Neurophysiology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan.
  • Department of Medical Science Project Planning and Support, The Corporation for Production and Research of Laboratory Primates, Tsukuba, Ibaragi 305-0003, Japan.
  • Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8502, Japan.
  • Integrative Brain Imaging Center, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.
  • Department of Integrated Neuroanatomy and Neuroimaging, Kyoto University Graduate School of Medicine, Sakyo, Kyoto 606-8501, Japan.
  • Life Science Research Institute, Kindai University, Osaka-Sayama, Osaka 589-8511, Japan.

ORCID-Profile: Eiko N Minakawa, Yosuke Saga, Satoru Noguchi, Takashi Hanakawa, Toshihide Takeuchi, Yoshitaka Nagai, Yuko Saito, Ikuo Tomioka, Kazuhiko Seki

Förderung

  • National Center of Neurology and Psychiatry
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Minakawa, E. N., Owari, K., Nogami, N., Nakatani, T., Koizumi, M., Kawanobe, A., Saga, Y., Kudo, M., Noguchi, S., Hanakawa, T., Hori, Y., Numazawa, H., Takeuchi, T., Katakai, Y., Saito, R., Nagai, Y., Saito, Y., Tomioka, I., & Seki, K. (2025). Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052470

Vancouver

Minakawa EN, Owari K, Nogami N, Nakatani T, Koizumi M, Kawanobe A, et al. Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease. Disease Models & Mechanisms. 2025. doi:10.1242/dmm.052470

BibTeX
@article{Minakawa2025,
  author = {Minakawa, Eiko N and Owari, Kensuke and Nogami, Naotake and Nakatani, Terumi and Koizumi, Masashi and Kawanobe, Akiyo and Saga, Yosuke and Kudo, Moeko and Noguchi, Satoru and Hanakawa, Takashi and Hori, Yuki and Numazawa, Hidemi and Takeuchi, Toshihide and Katakai, Yuko and Saito, Ryoichi and Nagai, Yoshitaka and Saito, Yuko and Tomioka, Ikuo and Seki, Kazuhiko},
  title = {Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease},
  journal = {Disease Models & Mechanisms},
  year = {2025},
  doi = {10.1242/dmm.052470}
}
Kostenlos starten →